ALGN Stock Surges 25% With A 5-day Spree On Strong Earnings & Upgrades
Align Technology (ALGN) – a designer and manufacturer of clear aligners and intraoral scanners – hit a 5-day winning streak, with cumulative gains over this period amounting to 25%. The company’s market cap has surged by about $2.8 Bil over the last 5 days and currently stands at $14 Bil.
The stock has YTD (year-to-date) return of 25.7% compared to 1.4% for S&P 500. This calls for a re-evaluation of the stock’s valuation to find out whether this is an opportunity or a trap.
What Triggered The Rally?
[1] Q4 2025 Earnings and Revenue Beat
- Decoding PLTR Stock’s Premium Valuation
- Intuit Stock: Strong Cash Flow Poised for a Re-Rating?
- Five-Year Tally: Lowe’s Companies Stock Delivers $50 Bil Gain
- Five-Year Tally: Mastercard Stock Delivers $60 Bil Gain
- Palantir Technologies Stock Hits Key Support – Buying Opportunity?
- Stronger Bet Than Ross Stores Stock: BURL, URBN Deliver More
- Reported Q4 adjusted EPS of $3.29, beating the $2.99 estimate
- Q4 revenue of $1.05 billion surpassed the consensus estimate of $1.03 billion
- Impact: Stock gapped up over 9% at open, Significant increase in trading volume
[2] Multiple Analyst Upgrades and Price Target Hikes
- HSBC upgraded the stock from Hold to Buy and raised its price target to $200
- Stifel, Wells Fargo, Piper Sandler, and Leerink Partners all raised their price targets
- Impact: Sustained buying pressure post-earnings, Positive shift in institutional sentiment
Opportunity or Trap?
Below is our take on valuation.
There are a few things to fear in ALGN stock given its overall Moderate operating performance and financial condition. But keeping in mind its High valuation, we think that the stock is Unattractive (For details, see Buy or Sell ALGN).
But here is the real interesting point.
You are reading about this 25% move after it happened. The market has already priced in the news. To catch the next winner before the headlines, you need predictive signals, not notifications. Our High Quality Portfolio has flagged 5 new opportunities that have not surged yet.
Returns vs S&P 500
The following table summarizes the return for ALGN stock vs. the S&P 500 index over different periods, including the current streak:
| Return Period | ALGN | S&P 500 |
|---|---|---|
| 1D | 2.0% | -0.3% |
| 5D (Current Streak) | 25.0% | 0.3% |
| 1M (21D) | 13.6% | -0.4% |
| 3M (63D) | 45.6% | 3.2% |
| YTD 2026 | 25.7% | 1.4% |
| 2025 | -25.1% | 16.4% |
| 2024 | -23.9% | 23.3% |
| 2023 | 29.9% | 24.2% |
However, big gains can follow sharp reversals – but how has ALGN behaved after prior drops? See ALGN Dip Buyer Analysis to learn more.
Gains and Losses Streaks: S&P 500 Constituents
There are currently 132 S&P constituents with 3 days or more of consecutive gains and 16 constituents with 3 days or more of consecutive losses.
| Consecutive Days | # of Gainers | # of Losers |
|---|---|---|
| 3D | 99 | 7 |
| 4D | 12 | 4 |
| 5D | 8 | 1 |
| 6D | 9 | 3 |
| 7D or more | 4 | 1 |
| Total >=3 D | 132 | 16 |
Key Financials for Align Technology (ALGN)
Last 2 Fiscal Years:
| Metric | FY2023 | FY2024 |
|---|---|---|
| Revenues | $3.9 Bil | $4.0 Bil |
| Operating Income | $656.7 Mil | $671.8 Mil |
| Net Income | $445.1 Mil | $421.4 Mil |
Last 2 Fiscal Quarters:
| Metric | 2025 FQ2 | 2025 FQ3 |
|---|---|---|
| Revenues | $1.0 Bil | $995.7 Mil |
| Operating Income | $163.0 Mil | $128.1 Mil |
| Net Income | $124.6 Mil | $56.8 Mil |
While ALGN stock looks attractive given its winning streak, investing in a single stock without detailed, thorough analysis can be risky. The Trefis High Quality (HQ) Portfolio, with a collection of 30 stocks, has a track record of comfortably outperforming its benchmark that includes all 3 — the S&P 500, S&P mid-cap, and Russell 2000 indices. Why is that? As a group, HQ Portfolio stocks provided better returns with less risk versus the benchmark index; less of a roller-coaster ride, as evident in HQ Portfolio performance metrics.